Publication:
Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction

Simple item page
dc.contributor.authorAkgul, Ozgur
dc.contributor.authorBaycan, Omer Faruk
dc.contributor.authorBulut, Umit
dc.contributor.authorSomuncu, Mustafa Umut
dc.contributor.authorPusuroglu, Hamdi
dc.contributor.authorOzyilmaz, Sinem
dc.contributor.authorGul, Mehmet
dc.contributor.authorDemir, Ali Riza
dc.contributor.authorYilmaz, Emre
dc.contributor.authorYazan, Serkan
dc.contributor.authorKokturk, Ugur
dc.contributor.authorCetin, Ilyas
dc.contributor.authorUyarel, Huseyin
dc.date.accessioned2020-10-22T21:36:58Z
dc.date.available2020-10-22T21:36:58Z
dc.date.issued2015-11-01T00:00:00Z
dc.description.abstractObjectives The prognostic value of pentraxin 3 (PTX3) has been documented in patients with acute coronary syndrome. However, its long-term prognostic value in acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the prognostic value of PTX3 in patients with STEMI undergoing a primary percutaneous coronary intervention (PCI).
dc.identifier.citationAkgul O., Baycan O. F. , Bulut U., Somuncu M. U. , Pusuroglu H., Ozyilmaz S., Gul M., Demir A. R. , Yilmaz E., Yazan S., et al., -Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction-, CORONARY ARTERY DISEASE, cilt.26, ss.592-597, 2015
dc.identifier.doi10.1097/mca.0000000000000280
dc.identifier.pubmed26061437
dc.identifier.scopus84942414413
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24882
dc.identifier.wosWOS:000369598000009
dc.titleLong-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction
dc.typeArticle
dspace.entity.typePublication
local.avesis.idf2a105fc-2d30-4bf1-9817-1409f19ae7cd
local.publication.isinternational1
Files
Collections
Yayınlar - Eserler